These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4830959)

  • 1. [Use of orciprenaline in the treatment of bronchospastic conditions].
    Semczuk B; Klonowski S; Czerwonka R; Golabek W; Czarnecki J; Czop S; Suwala H
    Pol Tyg Lek; 1974 Apr; 29(17):729-32. PubMed ID: 4830959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of spastic bronchitis with a new bronchospasmolytic agent].
    Heller K
    Wien Med Wochenschr; 1972 Oct; 122(42):606-9. PubMed ID: 5081450
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 5. Metaproterenol, a new bronchodilator:: comparison with isoproterenol.
    Pelz HH
    Am J Med Sci; 1967 Mar; 253(3):321-4. PubMed ID: 6021691
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of inhalation of an atropine derivative (SCH 1000) on airway resistance to flow and on specific conductance in patients with chronic obstructive bronchopneumopathy].
    Anastasatu C; Duţu S
    Ftiziologia; 1974 May; 23(3):305-10. PubMed ID: 4842470
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of bronchodilating effects and action on the cardiovascular system of 2 sympathomimetic agents: berotec and alupent].
    Zieliński J; Chodosowska E; Koziorowski A
    Gruzlica; 1973 Dec; 41(12):1249-58. PubMed ID: 4774750
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled evaluation of bromhexine and orciprenaline in the treatment of chronic bronchitis.
    McIntosh D
    Br J Clin Pract; 1971 Dec; 25(12):547-54. PubMed ID: 4947164
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sympathomimetics in the treatment of bronchospastic conditions].
    May KL
    Gruzlica; 1974 Jul; 42(7):711-7. PubMed ID: 4601911
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spasmolytic and mucolytic agents in the treatment of acute dyspneic pneumopathies in children].
    Manicatide ET; Căpraru H
    Pediatria (Bucur); 1973; 22(4):357-60. PubMed ID: 4761443
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of deptropine citrate aerosol with and without isoprenaline on airway obstruction.
    Ripe E
    Allerg Asthma (Leipz); 1970; 16(1):41-52. PubMed ID: 5466222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of orally administered Salbutamol (Ventolin) and orciprenaline in patients with reversible bronchospasm].
    Müller J; Zieliński J
    Gruzlica; 1973 Nov; 41(11):1155-62. PubMed ID: 4765796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhalation or peroral therapy with bronchospasmolytics].
    Kaik G; Bonelli J; Magometschnigg D
    Wien Med Wochenschr; 1977; 127(1):22-8. PubMed ID: 138266
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of a new beta-stimulator (Th 1165a, parahydroxyphenylorciprenaline) on the pulmonary function in chronic obstruction].
    Grabner H; Koller H; Kummer F
    Wien Z Inn Med; 1972; 53(12):639-45. PubMed ID: 4671749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Nolte D
    Arzneimittelforschung; 1971 Oct; 21(10):1453-6. PubMed ID: 5171859
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new drug for chronic treatment of bronchospastic states].
    Titscher R
    Wien Med Wochenschr; 1971 Feb; 121(8):146-7. PubMed ID: 5546540
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bronchodilating effects of an orciprenaline derivative].
    Anastasatu C; Jienescu Z; Duţu S
    Ftiziologia; 1972; 21(6):593-8. PubMed ID: 4644837
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the therapy of bronchospastic states in anesthesia. 1-(3-5-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane sulfate].
    Carta M
    Minerva Anestesiol; 1966 Jun; 32(6):315-8. PubMed ID: 5918368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etimizol in the treatment of chronic bronchitis complicated by bronchial spasm, and bronchial asthma].
    Andriushchenko OM; Krasnova LI
    Klin Med (Mosk); 1982 Nov; 60(11):43-6. PubMed ID: 7154629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.